Kaposi's sarcoma-associated herpesvirus, the etiological agent of all epidemiological forms of Kaposi's sarcoma

A Jary, M Veyri, A Gothland, V Leducq, V Calvez… - Cancers, 2021 - mdpi.com
Simple Summary Kaposi's sarcoma-associated herpesvirus (KSHV) is one of the seven
oncogenic viruses currently recognized by the International Agency for Research on Cancer …

Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC)

C Lebbe, C Garbe, AJ Stratigos, C Harwood… - European Journal of …, 2019 - Elsevier
Kaposi's sarcoma (KS) is a multifocal neoplasm of lymphatic endothelium-derived cells
infected with human herpesvirus 8. Four clinical subtypes are distinguished: the classic, the …

CAR T-cell therapy for cancer and HIV through novel approaches to HIV-associated haematological malignancies

BJ Rust, HP Kiem, TS Uldrick - The Lancet Haematology, 2020 - thelancet.com
People living with HIV are a global population with increased cancer risk but their access to
modern immunotherapies for cancer treatment has been limited by socioeconomic factors …

Kaposi sarcoma rates among persons living with human immunodeficiency virus in the United States: 2008—2016

Q Luo, A Satcher Johnson, HI Hall… - Clinical Infectious …, 2021 - academic.oup.com
Background Recent studies have suggested that Kaposi sarcoma (KS) rates might be
increasing in some racial/ethnic groups, age groups, and US regions. We estimated recent …

Spectrum and Incidence Trends of AIDS-and Non–AIDS-Defining Cancers between 2010 and 2015 in the French Dat'AIDS Cohort

I Poizot-Martin, C Lions, C Allavena, T Huleux… - … Biomarkers & Prevention, 2021 - AACR
Background: Cancer risk is higher in people living with HIV (PLWH) compared with the
general population, and cancers related to age are expected to be most prevalent. Methods …

CD4/CD8 ratio and the risk of Kaposi sarcoma or non-Hodgkin lymphoma in the context of efficiently treated human immunodeficiency virus (HIV) infection: a …

F Caby, M Guiguet, L Weiss, A Winston… - Clinical Infectious …, 2021 - academic.oup.com
Background A persistently low CD4/CD8 ratio has been reported to inversely correlate with
the risk of non-AIDS defining cancer in people living with human immunodeficiency virus …

HIV-related skin disease in the era of antiretroviral therapy: recognition and management

K Chelidze, C Thomas, AY Chang… - American journal of …, 2019 - Springer
Antiretroviral therapy (ART) has revolutionized the treatment and prognosis of people living
with HIV (PLHIV). With increased survival and improved overall health, PLHIV are …

Combination antiretroviral therapy and cancer risk

ÁH Borges - Current Opinion in HIV and AIDS, 2017 - journals.lww.com
The relationship between cART exposure and cancer risk is complex and nuanced. It is an
intriguing fact that, whether initiated during severe immunosuppression or not, cART …

Comparison of Kaposi sarcoma risk in human immunodeficiency virus-positive adults across 5 continents: a multiregional multicohort study

Clinical infectious diseases, 2017 - academic.oup.com
Abstract Background We compared Kaposi sarcoma (KS) risk in adults who started
antiretroviral therapy (ART) across the Asia-Pacific, South Africa, Europe, Latin, and North …

New Kaposi's sarcoma-associated herpesvirus variant in men who have sex with men associated with severe pathologies

A Jary, V Leducq, N Desire, H Petit… - The Journal of …, 2020 - academic.oup.com
Background Kaposi sarcoma (KS)–associated herpesvirus (KSHV) subtype depends mostly
on patient origin. The current study aimed to assess KSHV diversity in a population of men …